Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

Peter Schmid, Stephen Y. Chui, Leisha A. Emens

Research output: Contribution to journal › Letter › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply'. Together they form a unique fingerprint.